Non-canonical PD-1 signaling in cancer and its potential implications in clinic

Programmed cell death 1 (PD-1)-based immunotherapy has revolutionized the treatment of various cancers. However, only a certain group of patients benefit from PD-1 blockade therapy and many patients succumb to hyperprogressive disease. Although, CD8 T cells and conventional T cells are generally con...

Descripción completa

Detalles Bibliográficos
Autores principales: Zha, Haoran, Jiang, Ying, Wang, Xi, Shang, Jin, Wang, Ning, Yu, Lei, Zhao, Wei, Li, Zhihua, An, Juan, Zhang, Xiaochun, Chen, Huoming, Zhu, Bo, Li, Zhaoxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888367/
https://www.ncbi.nlm.nih.gov/pubmed/33593825
http://dx.doi.org/10.1136/jitc-2020-001230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888367/
https://www.ncbi.nlm.nih.gov/pubmed/33593825
http://dx.doi.org/10.1136/jitc-2020-001230

Ejemplares similares